Showing results (311-320 of 658) with videos related to
Sort By:
Pageof 66
Cancer Research|September 1, 2017
Exosomes from Glioma-Associated Mesenchymal Stem Cells Increase the Tumorigenicity of Glioma Stem-like Cells via Transfer of miR-1587Javier Figueroa, Lynette M Phillips, Tal Shahar, et al.Cells|October 23, 2021
Measuring the Metabolic Evolution of Glioblastoma throughout Tumor Development, Regression, and Recurrence with Hyperpolarized Magnetic ResonanceTravis C Salzillo, Vimbai Mawoneke, Joseph Weygand, et al.Cancers|November 13, 2021
Intrinsic Interferon Signaling Regulates the Cell Death and Mesenchymal Phenotype of Glioblastoma Stem CellsSabbir Khan, Rajasekaran Mahalingam, Shayak Sen, et al.Neuro-Oncology|February 13, 2010
MGMT promoter methylation is predictive of response to radiotherapy and prognostic in the absence of adjuvant alkylating chemotherapy for glioblastomaAndreana L Rivera, Christopher E Pelloski, Mark R Gilbert, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|May 17, 2008
Long-term anti-inflammatory and antihistamine medication use and adult glioma riskMichael E Scheurer, Randa El-Zein, Patricia A Thompson, et al.Molecular Cancer Research : MCR|September 23, 2016
The Cytoskeletal Adapter Protein Spinophilin Regulates Invadopodia Dynamics and Tumor Cell Invasion in GlioblastomaMujeeburahiman Cheerathodi, Naze G Avci, Paola A Guerrero, et al.Magnetic Resonance Imaging Clinics of North America|October 16, 2016
Interrogating Metabolism in Brain CancerTravis C Salzillo, Jingzhe Hu, Linda Nguyen, et al.Journal of Neuro-Oncology|May 20, 2015
Venous thromboembolism (VTE) and glioblastomaShlomit Yust-Katz, Jacob J Mandel, Jimin Wu, et al.Brain Tumor Pathology|November 13, 2014
C11orf95-RELA fusion present in a primary supratentorial ependymoma and recurrent sarcomaDavid Cachia, Khalida Wani, Marta Penas-Prado, et al.Neuro-Oncology Practice|March 9, 2026
The impact of neighborhood-level disadvantage on symptoms, mood, and health-related quality of life among the primary brain tumor populationZuena Karim, Kimberly Robins, Orieta Celiku, et al.Pageof 66